Home | PHARMAC
Home | PHARMAC
  • Website
  • Application Tracker
  • Schedule
  • About PHARMAC
    • About PHARMAC
    • Your guide to PHARMAC
    • Our people
    • Careers at PHARMAC
    • Expert advice
    • PHARMAC's performance
    • Operating policies and procedures
    • Year in Review 2018/2019
    • Strategies
  • Medicines
    • Medicines
    • How medicines are funded
    • Medicines information
    • My medicine or medical device has changed
    • Your health
    • Hospital pharmaceuticals
    • New medicines – from development to funding
    • Equity
  • Hospital devices
    • Hospital devices
    • Feedback on managing fairer access to hospital medical devices
    • What's happening in each category?
    • About our role in device management
    • Device Advice
  • News (current)
  • Te Whaioranga
    • Te Whaioranga
    • Te Whaioranga 2013 - 2023: Māori Responsiveness Strategy
    • Whānau Ora
    • He Rongoā Pai, He Oranga Whānau
    • Scholarships
    • Hauora Arotahi - Māori health areas of focus
    • Māori Responsiveness Team
    • One Heart Many Lives
  • Pacific
    • Pacific
    • Pacific responsiveness strategy 2017-2026
    • Stage one: Pacific Responsiveness Strategy
  • Tools & resources
    • Tools & resources
    • Pharmaceutical Schedule
    • Annual Procurement Plan
    • Forms
    • Research
    • Print and PDF resources
    • Glossary
    • PHARMAC labelling preferences for prescription pharmaceuticals
  • Information for…

News

  • Media releases
  • Notifications
  • Consultations
  • Tenders
  • RFPs
  • OIA responses

News

Consultations

Proposal to list medical devices supplied by Intermed Medical Limited

05/09/2018

PHARMAC is seeking feedback on a proposal to list a range of medical devices in Part III of Section H of the Pharmaceutical Schedule from 1 November 2018, through a provisional agreement with Intermed Medical Limited.

Closes:  4pm Wednesday, 26 September 2018.

Consultations

Proposal to list sapropterin for use in pregnancy by women with phenylketonuria

30/08/2018

PHARMAC is seeking feedback on a proposal to fund sapropterin tablets, a treatment for the rare condition phenylketonuria (PKU), for women who are pregnant or actively planning a pregnancy and require pharmacological support to manage PKU in pregnancy.

Consultation closes at 12 noon on Monday, 17 September 2018.

Consultations

Proposal to list a range of orthopaedic implants and associated products supplied by Mathys Limited

30/08/2018

PHARMAC is seeking feedback on a proposal to list a range of orthopaedic implants and associated products supplied by Mathys Limited ("Mathys") in Part III of Section H of the Pharmaceutical Schedule from 1 November 2018.  

Consultation closes at 5pm on Thursday, 20 September 2018.

Consultations

Proposal to move to one funded brand of lamotrigine (Logem)

29/08/2018

PHARMAC is seeking feedback on a proposed change to the funding of lamotrigine dispersible tablets used in the treatment of epilepsy and/or bipolar disorder.

Consultation closes at 4 pm on Wednesday, 26 September 2018.

Consultations

Proposal to list urology, ostomy and continence products supplied by Convatec (New Zealand) Limited

28/08/2018

PHARMAC is seeking feedback on a proposal to list a range of urology, ostomy and continence products in Part III of Section H of the Pharmaceutical Schedule from 1 November 2018, through a listing agreement with Convatec (New Zealand) Limited

Closes:  4pm Tuesday, 18 September 2018.

Consultations

Update on proposal to fund a pangenotypic hepatitis C treatment - glecaprevir and pibrentasvir (Maviret)

27/08/2018

PHARMAC have determined that we require additional time to consider the issues raised as a result of our consultation of 20 July 2018 before a decision can be made on the proposal.

Consultations

Proposal to list medical devices supplied by Jackson Allison Medical & Surgical Limited

27/08/2018

PHARMAC is seeking feedback on a proposal to list a range of medical devices in Part III of Section H of the Pharmaceutical Schedule from 1 November 2018, through a provisional agreement with Jackson Allison Medical & Surgical Limited.

Closes:  4pm Friday, 14 September 2018.

Consultations

Notice of Information - Supply of laboratory equipment and consumables

24/08/2018

This Notice of Information is to provide advance notification to the market of PHARMAC's intention to release an RFP (Request for Proposal) for the supply of laboratory equipment and consumables.  The RFP is intended to be released via the Government Electronic Tenders Service (GETS) in mid-September 2018.

Consultations

Proposal to list continence products supplied by Universal Specialities Limited

23/08/2018

PHARMAC is seeking feedback on a proposal to list a range of continence products in Part III of Section H of the Pharmaceutical Schedule from 1 November 2018, through a listing agreement with Universal Specialities Limited.

Closes:  4pm Thursday, 13 September 2018.

Consultations

Proposal to change the funded brand of epoetin alfa

21/08/2018

PHARMAC is seeking feedback on a proposed change to the funded brand of epoetin alfa [erythropoietin alfa] injections used in the treatment of chronic renal failure and myelodysplasia.

Consultation closes at 4 pm on Monday, 10 September 2018.

Consultations

Proposal to list nintedanib (Ofev), and remove restrictions from tiotropium bromide (Spiriva)

20/08/2018

PHARMAC is seeking feedback on a proposal to list nintedanib (Ofev) and remove the current funding restrictions from tiotropium (Spiriva and Spiriva Respimat) from 1 October 2018, through a provisional agreement with Boehringer Ingelheim NZ Limited.

Consultation closes at 4 pm on Tuesday, 4 September 2018.

Consultations

Proposal to list medical devices supplied by Draeger New Zealand Limited

13/08/2018

PHARMAC is seeking feedback on a proposal to list a range of anaesthesia and respiratory care products in Part III of Section H of the Pharmaceutical Schedule from 1 October 2018 through a provisional agreement with Draeger New Zealand Limited.

Closes:  4pm Friday, 31 August 2018.

Consultations

2018/19 invitation to tender (suppliers)

03/08/2018

PHARMAC is seeking feedback from pharmaceutical suppliers and interested parties on:

  • A proposal to tender certain pharmaceuticals for sole supply;
  • The draft process and terms and conditions for the 2018/19 Invitation to Tender (2018/19 Tender); and
  • Commercial proposals as an alternative to tendering.

PHARMAC welcomes all feedback on the draft 2017/18 Tender.   

Alternative commercial proposal responses due by 5 pm, Monday 27 AUGUST 2018

All other consultation responses due by 5 pm, Thursday 6 SEPTEMBER 2018

Consultations

2018/19 invitation to tender (medical)

03/08/2018

PHARMAC is seeking feedback from medical groups, DHB hospital pharmacies and other interested parties on:

  • A proposal to tender certain pharmaceuticals for sole supply; and
  • The draft process and terms and conditions for the 2018/19 Invitation to Tender (2018/19 Tender).

PHARMAC welcomes all feedback on the 2018/19 Tender.

All responses are due by 5pm, Thursday 6 September 2018

Consultations

Proposal to list Interventional Radiology and respiratory products from Getz Healthcare Ltd

31/07/2018

PHARMAC is seeking feedback on a proposal to list a range of interventional radiology and respiratory care products in Part III of Section H of the Pharmaceutical Schedule from 1 October 2018 through a provisional agreement with Getz Healthcare Ltd (‘Getz’).

Consultation closes at 5pm on Friday, 17 August 2018.

Consultations

Proposal to list medical devices supplied by EBOS Group Limited and Talgram Health (NZ) Ltd

31/07/2018

PHARMAC is seeking feedback on a proposal to list a range of medical devices in Part III of Section H of the Pharmaceutical Schedule from 1 October 2018 through  provisional agreements with EBOS Group Limited and Talgram Health (NZ) Ltd.

Consultation closes at 4pm on Friday, 17 August 2018.

Consultations

Proposal to list medical devices supplied by Device Technologies New Zealand Limited and Medipak Surgical NZ Limited

25/07/2018

PHARMAC is seeking feedback on a proposal to list a range of medical devices in Part III of Section H of the Pharmaceutical Schedule from 1 October 2018, through individual provisional agreements with the following suppliers (Closes 15 August 2018).

Consultations

Proposal to fund a pangenotypic hepatitis C treatment - glecaprevir and pibrentasvir (Maviret)

20/07/2018

PHARMAC is seeking feedback on a proposal to fund a pangenotypic treatment for chronic hepatitis C infection, glecaprevir and pibrentasvir (Maviret), through a provisional agreement with AbbVie Ltd.  And we also seek feedback on the proposed distribution arrangements.

Consultation closes at 5 pm on Monday, 13 August 2018.

Consultations

Proposal to modify the transition between funded brands in the Schedule

13/07/2018

PHARMAC is seeking feedback on a proposal to simplify the transition period for changes made to community medicines by removing the referencing pricing period during brand changes. 

Consultation closes at 5 pm, Friday 10 August 2018.

Consultations

Proposal to list Interventional Radiology products supplied by Bio-Excel (New Zealand) Ltd and Biotronik Australia PTY Limited

11/07/2018

PHARMAC is seeking feedback on a proposal to list a range of Interventional Radiology Products in Part III of Section H of the Pharmaceutical Schedule from 1 September 2018 through provisional agreements with Bio-Excel (New Zealand) Ltd (‘Bio-Excel’) and Biotronik Australia PTY Limited (“Biotronik”).

Consultation closes at 5pm on Friday, 27 July 2018.

  • 1
  • ...
  • 4
  • 5
  • 6
  • 7
  • 8
  • ...
  • 21

Newsletters

Make our website better – take a short survey

Device Advice: Your update on PHARMAC’s Hospital Medical Devices programme.


 PHARMACnz Twitter    PHARMACnz Facebook    PHARMAC in LinkedIn


Media queries

For media queries, contact:

021 863 342

media@pharmac.govt.nz

Media phone is monitored 9am–5pm weekdays

About this site

  • Sitemap
  • Copyright
  • Disclaimer
  • Privacy statement
  • Website changes
  • About this site

Contact

  • Contact us
  • Twitter - PHARMACnz
  • Facebook - PHARMACnz
  • YouTube - PHARMACgovtnz
  • LinkedIn - Pharmaceutical Management Agency (PHARMAC)
  • Careers
  • Newsfeed
  • Subscribe

Back to top

New Zealand Government